Please assess the completion status of the following clinical trial:

Trial Title: Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Adults (age 18 to 65 years of age), male or female Hispanic or Caucasian.~2. Primary kidney or kidney transplant patients (cadaveric, living related, or living unrelated)~3. Written inform consent obtained. The patients are willing to participate in the study at UTMB.~4. Female with negative pregnancy test.~5. PRA \< 20 %.~6. En-blocks and two kidneys (tx'd at the same time) will be allowed.~7. Cold Ischemia time ≤ 30 hrs~8. Hep C patients will be allowed to enroll in this study~Exclusion Criteria:~1. Multi-organ transplants~2. Transplant from non-heart beating donor (NHBD) or dual transplants~3. A-B-O incompatible or positive cross match~4. Conditions which significantly alter the absorption, distribution, and metabolism (except for diarrhea) of medications.~5. Women of childbearing potential not using contraception method(s) as well as women who are breastfeeding~6. Inability to tolerate oral medications~7. Inability to sign a written consent form or to cooperate with investigators~8. Use of an investigational medication in the past 30 days.~9. Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study (specify as required)~10. HIV positive patients~11. History of psychosocial instability~12. Mental incompetence

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Transplant recipients (Type: EXPERIMENTAL): All subjects receive identical drug treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).